Exclusive, real-time OTC pricing from ICAP, Tullett Prebon and PVM now available through ICE’s consolidated feed
London, September 2, 2026 –Parameta Solutions, the data and analytics division of TP ICAP Group, and Intercontinental Exchange, Inc. (NYSE: ICE), one of the world’s leading providers of financial market technology and data powering global financial markets, have announced an expanded agreement to distribute Parameta’s global over-the-counter (OTC) market data through the ICE Consolidated Feed.
Much of the world’s trading activity takes place over the counter (OTC), where transactions are negotiated directly between counterparties, and transparency into pricing and liquidity can be limited.
The expanded relationship allows ICE to offer Parameta’s differentiated OTC market data across asset classes including linear and non-linear rates, inflation, fixed income, credit, FX, FX options, money markets and energy. Sourced from the world’s largest interdealer broker, including leading brokerage brands ICAP, Tullett Prebon and PVM, the data enhances visibility into OTC markets alongside the exchange-traded data already available through ICE’s consolidated feed.
The ICE Consolidated Feed aggregates content from 600+ data streams in a normalized format. Used by banks, asset managers, hedge funds, ISVs and redistributors, the ICE Consolidated Feed delivers a broad range of global information with multi-asset coverage, including equities, derivatives, fixed income, foreign exchange, money markets, commodities, energy and ETFs.
ICE clients can seamlessly access streaming pricing and market intelligence through a single, normalised data feed, providing a more complete view of market activity and price formation. Parameta’s data is delivered through existing workflows, reducing integration complexity to help enable more informed trading decisions.
“Many firms want a clearer and more complete view of markets beyond the exchanges, but without adding complexity to their data infrastructure,” said Lisa Ward, Head of Channel Distribution at Parameta Solutions. “By combining the depth of liquidity and market expertise within TP ICAP Group with ICE’s global distribution capabilities, we are making hard-to-source OTC market data more accessible, usable and actionable. Alongside ICE’s exchange-traded data, this provides a more holistic view of market activity and supports clients in making better-informed trading decisions.”
The expanded distribution relationship reinforces both companies’ commitment to improving market transparency and providing clients with flexible access to high-quality market data across both OTC and exchange-traded markets.
Disclaimer
© 2026 ICAP Information Services Limited (“IISL”). This communication is provided by ICAP Information Services Limited or a member of its group (“Parameta”) and all information contained in or attached hereto (the “Information”) is for information purposes only and is confidential. Access to the Information by anyone other than the intended recipient is unauthorised without Parameta’s prior written approval. The Information may not be not used or disclosed for any purpose without Parameta’s prior written approval, including without limitation, storing, copying, distributing, licensing, selling or displaying the Information, using the Information in an application or to create derived data of any kind, co-mingling the Information with any other data or using the data for any unlawful purpose of for any purpose that would cause it to become a benchmark under any law, regulation or guidance. The Information is not, and should not be construed as, a live price, an offer, bid, recommendation or solicitation in relation to any financial instrument or investment or to participate in any particular trading strategy or constituting financial or investment advice or a financial promotion. The Information does not constitute a public offer under any applicable legislation or an offer to sell or a solicitation of an offer to buy any securities. The Information is not to be relied upon for any purpose whatsoever and is provided “as is” without warranty of any kind, either expressly or by implication, including without limitation as to completeness, timeliness, accuracy, continuity, merchantability or fitness for any particular purpose. All representations and warranties are expressly disclaimed, to the fullest extent possible under applicable law. In no circumstances will Parameta be liable for any indirect or direct loss, or consequential loss or damages including without limitation, loss of business or profits arising from the use of or any inability to use the Information, or any inaccuracy in the Information. Parameta may suspend, withdraw or modify or change the terms of the provision of the Information at any time in its sole discretion, without notice. All rights, including without limitation intellectual property rights, in and to the Information are, and shall remain, the property of IISL or its licensors. Use of, access to or delivery of Parameta’s products and/or services requires a prior written licence from Parameta or its relevant affiliates. The terms of this disclaimer are governed by the laws of England and Wales.
Latest Insights
See All
MCP, AI and the Future of OTC Market Data: Why Context Matters More Than Ever
Why independent fixings matter for derivatives and structured products
